Skip to main content
Biotage logo

Biotage — Investor Relations & Filings

Ticker · BIOT ISIN · SE0000454746 LEI · 529900SR87NBUKX74L58 ST Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2013-05-31 Declaration of Voting R…
Country SE Sweden
Listing ST BIOT

About Biotage

https://www.biotage.com/

Biotage is a global life science company specializing in separation and purification technologies. It provides systems, consumables, and intelligent workflow solutions for customers in drug discovery and development, analytical testing, and diagnostics. The company's portfolio supports a wide range of applications, including medicinal chemistry, peptide synthesis, biomolecule purification (proteins, DNA, oligonucleotides), and automated sample preparation. Key technologies are applied in flash chromatography and analytical testing for clinical, forensic, and environmental samples. Biotage focuses on streamlining laboratory processes to advance scientific research and human health.

Recent filings

Filing Released Lang Actions
Biotage AB – changes in number of shares and votes
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is a short press release dated May 31, 2013, announcing a change in the number of outstanding shares and votes following a resolution made at the Annual General Meeting (AGM) on April 25, 2013, specifically related to the withdrawal of repurchased shares. This action directly relates to a change in the company's capital structure (share count). The most fitting category is 'Share Issue/Capital Change' (SHA), as it details the final resulting share count after a capital action (share withdrawal/cancellation). While it mentions the AGM, the core subject is the resulting share count change, not the AGM materials themselves (AGM-R) or a general regulatory filing (RNS). It is not a dividend announcement (DIV) or a transaction in own shares (POS), as POS usually refers to the *act* of buying back/selling, whereas this reports the *result* of a previously authorized cancellation.
2013-05-31 English
Biotage AB inleder återköp av egna aktier
Transaction in Own Shares Classification · 98% confidence The document is a press release from Biotage AB dated April 26, 2013, titled "Biotage AB inleder återköp av egna aktier" (Biotage AB initiates repurchase of own shares). The text explicitly states that the Board has decided to initiate a share repurchase program based on the authorization granted at the Annual General Meeting (AGM) on April 25, 2013. This action—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. Therefore, the appropriate filing code is POS.
2013-04-26 Swedish
Biotage AB launches share buy-back
Transaction in Own Shares Classification · 98% confidence The document is a press release from Biotage AB dated April 26, 2013, announcing that the board has resolved to start a share buyback program. The text explicitly discusses the acquisition and sale of the company's own shares, referencing authorization from the Annual General Meeting. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchases.
2013-04-26 English
Resolutions at the Annual General Meeting in Biotage AB on April 25, 2013
AGM Information Classification · 99% confidence The document is explicitly titled 'Resolutions at the Annual General Meeting in Biotage AB on April 25, 2013'. It details specific decisions made during this meeting, such as dividend appropriation, election of the Board of Directors, auditor appointments, and authorizations regarding share capital and treasury shares. These contents are characteristic of the formal documentation released following an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R (AGM Information).
2013-04-25 English
Beslut vid årsstämman i Biotage AB den 25 april 2013
AGM Information Classification · 98% confidence The document is titled "Beslut vid årsstämman i BiotageAB den 25 april 2013" (Decisions at the Annual General Meeting in BiotageAB on April 25, 2013). It details specific resolutions passed at the meeting, including decisions on dividend distribution, board composition, auditor appointment, remuneration, capital reduction, and authorizations for future share issues. These topics are central to the proceedings and outcomes of an Annual General Meeting (AGM). Since the text explicitly details the decisions made at the AGM, the most appropriate classification is AGM Information (AGM-R). It is not a proxy statement (PSI) as it reports the results, nor is it a general regulatory filing (RNS) given the specific nature of the content.
2013-04-25 Swedish
Interim / Quarterly Report 2013
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the period January-March 2013. It contains comprehensive financial statements, including income statements, balance sheet data, cash flow analysis, management commentary, and operational updates. It is not an announcement of a report, but the report itself, containing substantive financial data. Therefore, it is classified as an Interim/Quarterly Report. Q1 2013
2013-04-25 Swedish

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.